Sweden· SE-19980402000038
NeoRecormon 2000 IE Injektionsvätska, lösning i förfylld spruta
A medicinal product containing epoetin beta, registered in Sweden by Roche Registration GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Epoetin Beta
- Manufacturer
- Roche Registration GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19980402000038
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epoetin beta in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEORECORMONRoche Registration GmbH, Grenzach-Wyhlen
- BelgiumNeoRecormon 2000 IURoche Registration
- SpainNEORECORMON 2000 UI SOLUCION INYECTABLE EN JERINGA PRECARGADARoche Registration Gmbh
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- IcelandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG*
- NetherlandsAbseamed 10.000 IE/1 ml oplossing voor injectie in een voorgevulde spuitMedice Arzneimittel Pütter GmbH & Co. KG
- PolandAbseamedMedice Arzneimittel Puetter GmbH & Co. KG
- IrelandAbseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.G
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Erypo
- Belgium · Eprex
- Czechia · Eprex
- Germany · Erypo Fs
- Spain · Eprex
- France · Eprex
- United Kingdom (Northern Ireland) · Eprex
- Greece · Eprex
- Iceland · Abseamed, Binocrit
- Italy · Eprex
- Liechtenstein · Binocrit, Epoetin Alfa Hexal
- Luxembourg · Eprex
- Netherlands · Eprex
- Norway · Abseamed, Binocrit
- Portugal · Eprex
- Slovenia · Eprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4d0b40bc-b30a-419f-9371-85699835339c GET /v1/drugs/4d0b40bc-b30a-419f-9371-85699835339c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "19980402000038",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19980402000038",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/neorecormon-epar-product-information_sv.pdf"
}See everything about epoetin beta.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.